Business Wire

SetPoint Medical Accepted into FDA Total Product Life Cycle Advisory Program for Development of its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, announced that it has been accepted into the Total ...

SetPoint Medical Announces First SetPoint® System Procedure in Texas, Performed at Ascension Dell Seton Medical Center at The University of Texas

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today announced the completion of the first procedure in Texas using the U.S. Food and ...
Yahoo Finance

FDA approves SetPoint’s neuroimmune modulation device for RA treatment

The US Food and Drug Administration (FDA) has approved SetPoint Medical’s implantable neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis (RA) in adults.
Business Wire

SetPoint Medical Appoints Murthy Simhambhatla as President and Chief Executive Officer

VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Murthy Simhambhatla ...